Correlation Between Alcon AG and Haemonetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alcon AG and Haemonetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alcon AG and Haemonetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alcon AG and Haemonetics, you can compare the effects of market volatilities on Alcon AG and Haemonetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alcon AG with a short position of Haemonetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alcon AG and Haemonetics.

Diversification Opportunities for Alcon AG and Haemonetics

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Alcon and Haemonetics is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Alcon AG and Haemonetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Haemonetics and Alcon AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alcon AG are associated (or correlated) with Haemonetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Haemonetics has no effect on the direction of Alcon AG i.e., Alcon AG and Haemonetics go up and down completely randomly.

Pair Corralation between Alcon AG and Haemonetics

Considering the 90-day investment horizon Alcon AG is expected to under-perform the Haemonetics. But the stock apears to be less risky and, when comparing its historical volatility, Alcon AG is 2.14 times less risky than Haemonetics. The stock trades about -0.3 of its potential returns per unit of risk. The Haemonetics is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  7,573  in Haemonetics on August 27, 2024 and sell it today you would earn a total of  1,273  from holding Haemonetics or generate 16.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Alcon AG  vs.  Haemonetics

 Performance 
       Timeline  
Alcon AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alcon AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Haemonetics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Haemonetics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Haemonetics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Alcon AG and Haemonetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alcon AG and Haemonetics

The main advantage of trading using opposite Alcon AG and Haemonetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alcon AG position performs unexpectedly, Haemonetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Haemonetics will offset losses from the drop in Haemonetics' long position.
The idea behind Alcon AG and Haemonetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA